Full-Time
Lindus Health
51-200 employees
Accelerates clinical trials for life sciences
No salary listed
Expert
London, UK
Flexible working; we have an incredible office near London Bridge and encourage people to work 3 days per week from the office.
- 10+ years of experience within either biostatistics or data management, developing, both working on the delivery of clinical trial data and managing a team in an academic or commercial setting
- Thrives in a startup environment that challenges the norms of typical CROs
- Loves working in a multidisciplinary team that includes clinical and technical collaborators as well as sponsor representatives
- Brings strategic and creative thinking, having had experience building out and implementing key processes from scratch
- Experience building and coaching a team of biostatisticians and/or data managers
- High agency and a bias for action
- Passionate and curious about the mission; changing how the healthcare industry operates and how new health treatments are developed
- Wants to learn what life is like at a high-growth, mission-driven VC funded startup
- Become a key member of the Clinical Operations leadership team
- Advise others across the company on trial data best practices
- Support Data Management and Biostatistics teams in audits
- Help the product team stay on top of the trial pipeline by capturing and prioritising new requirements for upcoming trials
- Establish the function from scratch, mentoring and coaching the existing biostatistician and data managers
- Establish key processes and approaches for how we deliver biostatistics and data management across our trials
- Lead on the development and implementation of training, SOPs and best practice ways of working
- Be accountable for the delivery of all biostatistics and data management work across all trials
- Act as the point of escalation both internally and with sponsors for statistics and data challenges where they arise
- Represent biostatistics and data management when working with prospect and existing customers
- Work closely with our solutions team on developing bids which accurately reflect the needs of biostatistics and data management
Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. By doing so, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, achieving results up to three times faster than conventional CROs and often completing trials ahead of schedule.
Company Size
51-200
Company Stage
Series B
Total Funding
$78.7M
Headquarters
London, United Kingdom
Founded
2021
Simplify's Take
What believers are saying
- Recent $55M funding will enhance AI technology and expand global operations.
- AI-driven recruitment strategies reduce patient enrollment time significantly.
- Growing demand for decentralized trials aligns with Lindus Health's patient-centric approach.
What critics are saying
- Increased competition from AI-driven trial companies threatens market position.
- Rapid AI advancements require continuous R&D investment to stay competitive.
- Data privacy concerns with EHR usage could lead to regulatory scrutiny.
What makes Lindus Health unique
- Lindus Health accelerates clinical trials, delivering results up to three times faster.
- Their proprietary AI technology enhances data standardization and trial efficiency.
- Access to 30 million Electronic Health Records boosts patient recruitment capabilities.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Unlimited Paid Time Off
Flexible Work Hours
Mental Health Support
Enhanced Parental Leave
Professional Development Budget
Cycle to work scheme
Stock Options
Regular team events
A new laptop as your main workstation
Growth & Insights and Company News
6 month growth
â -4%1 year growth
â -4%2 year growth
â 9%CDISC is collaborating with Lindus Health, which is utilizing its proprietary AI technology, to accelerate the generation of Biomedical Concepts across both the CDISC Foundational Standards as well as the Therapeutic Area Standards.
Lindus Health, a London-based startup, has raised $55 million in a Series B funding round led by Balderton Capital, with participation from Creandum, Firstminute, Seedcamp, and Visionaries Club. The company aims to revolutionize clinical trials using AI and automation, facilitating faster drug market entry. Lindus Health plans to relocate its global headquarters to the US, expand its commercial team, and enhance AI-driven clinical trial data analysis.
Lindus Health, a NYC-based clinical trial company, raised $55M in Series B funding led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp. The funds will enhance their AI technology and eClinical platform, Citrusâ˘, for optimizing study design and data monitoring. Since its 2021 launch, Lindus Health has conducted 42 trials, enrolling over 36,000 patients in North America and Europe.
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched their "all-in-one" contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.Cardiovascular disease is the leading cause of death in both men and women as well as most racial groups in the US. Clinical trials for these conditions require large, diverse participant populations to capture variability in disease presentation and risk factors, along with extended follow-up to assess long-term outcomes and quality of life improvements. Implementing patient-centric approaches in these studies, like remote-monitoring or decentralized trial designs, is also critical to reduce barriers to participation and observe how these interventions perform in the real world. Lindus Health's latest offering equips sponsors with all the necessary resources to navigate these distinct challenges and more that come with conducting clinical trials in the cardiovascular space.To date, Lindus Health has enrolled over 8,000 patients in cardiovascular studies across the US, UK, and EU. Their "All-in-One Cardiovascular CRO" includes end-to-end CRO and site services, industry knowledge, and eClinical technology necessary for sponsors developing therapies and devices to treat and monitor cardiovascular indications."Patient experience is paramount in cardiovascular studies," said Meri Beckwith, co-founder at Lindus Health
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has introduced their versatile contract research organization (CRO), site, and technology offering tailor-made to the execution of infectious disease trials.Clinical development of infectious disease treatments and diagnostics must account for complexities such as diverse and evolving pathogens, seasonality and localization of study sites, and enrollment at the appropriate time during infection. Having enrolled over 5,000 patients in infectious disease studies across the US, EU, and UK, Lindus Health is well-equipped to handle the unique challenges within this therapeutic area.Lindus Health's latest solution for the infectious disease market segment leverages their full-spectrum CRO and site services, rooted in deep expertise in running infectious disease clinical trials. They are able to recruit diverse study populations at twice the speed of traditional CROs through their expansive recruitment capabilities, including targeted digital outreach campaigns, healthcare and community organization collaborations, and electronic health record (EHR) screening from a repository of over 30 million patients."Infectious disease studies require swift and adaptable approaches for execution and recruitment to keep pace with evolving pathogens and public health needs," said Meri Beckwith, co-founder of Lindus Health. "Therefore speed of execution and access to real-time data are essential, while ensuring enrollment of diverse and representative patient populations."The "All-in-One Infectious Disease CRO" offers a comprehensive suite of resources and services to support infectious disease research, including:Full-service CRO solutions: From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities.From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities. Innovative recruitment strategies : With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies.: With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies